126 related articles for article (PubMed ID: 31731087)
1. Neurotoxicity of antibodies in cancer therapy: A review.
Horta E; Bongiorno C; Ezzeddine M; Neil EC
Clin Neurol Neurosurg; 2020 Jan; 188():105566. PubMed ID: 31731087
[TBL] [Abstract][Full Text] [Related]
2. Risk of Neurological Toxicities Following the Use of Different Immune Checkpoint Inhibitor Regimens in Solid Tumors: A Systematic Review and Meta-analysis.
Xu M; Nie Y; Yang Y; Lu YT; Su Q
Neurologist; 2019 May; 24(3):75-83. PubMed ID: 31045716
[TBL] [Abstract][Full Text] [Related]
3. Peripheral neuropathy and headache in cancer patients treated with immunotherapy and immuno-oncology combinations: the MOUSEION-02 study.
Rizzo A; Santoni M; Mollica V; Logullo F; Rosellini M; Marchetti A; Faloppi L; Battelli N; Massari F
Expert Opin Drug Metab Toxicol; 2021 Dec; 17(12):1455-1466. PubMed ID: 35029519
[TBL] [Abstract][Full Text] [Related]
4. Reversible metronidazole-induced neurotoxicity after 10 weeks of therapy.
AlDhaleei W; AlMarzooqi A; Gaber N
BMJ Case Rep; 2018 Apr; 2018():. PubMed ID: 29678819
[TBL] [Abstract][Full Text] [Related]
5. Anticancer Drugs and the Nervous System.
Santomasso BD
Continuum (Minneap Minn); 2020 Jun; 26(3):732-764. PubMed ID: 32487905
[TBL] [Abstract][Full Text] [Related]
6. Immune checkpoint inhibitor associated neurotoxicity: Much more than meets the eye.
Raibagkar P
Immunol Lett; 2020 May; 221():72-74. PubMed ID: 32092358
[No Abstract] [Full Text] [Related]
7. Pediatric chemotherapy induced peripheral neuropathy: A systematic review of current knowledge.
Kandula T; Park SB; Cohn RJ; Krishnan AV; Farrar MA
Cancer Treat Rev; 2016 Nov; 50():118-128. PubMed ID: 27664395
[TBL] [Abstract][Full Text] [Related]
8. Optimal clinical assessment strategies for chemotherapy-induced peripheral neuropathy (CIPN): a systematic review and Delphi survey.
McCrary JM; Goldstein D; Boyle F; Cox K; Grimison P; Kiernan MC; Krishnan AV; Lewis CR; Webber K; Baron-Hay S; Horvath L; Park SB;
Support Care Cancer; 2017 Nov; 25(11):3485-3493. PubMed ID: 28589310
[TBL] [Abstract][Full Text] [Related]
9. Neurologic Immune-Related Adverse Events Associated with Immune Checkpoint Inhibition.
Pan PC; Haggiagi A
Curr Oncol Rep; 2019 Nov; 21(12):108. PubMed ID: 31776691
[TBL] [Abstract][Full Text] [Related]
10. EGFR, HER2 and VEGF pathways: validated targets for cancer treatment.
Press MF; Lenz HJ
Drugs; 2007; 67(14):2045-75. PubMed ID: 17883287
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy-induced neuropathies-a growing problem for patients and health care providers.
Banach M; Juranek JK; Zygulska AL
Brain Behav; 2017 Jan; 7(1):e00558. PubMed ID: 28127506
[TBL] [Abstract][Full Text] [Related]
12. Challenges Evaluating Chemotherapy-Induced Peripheral Neuropathy in Childhood Cancer Survivors.
Mohrmann C; Armer J; Hayashi RJ
J Pediatr Oncol Nurs; 2017; 34(2):106-114. PubMed ID: 27251891
[TBL] [Abstract][Full Text] [Related]
13. Four-in-one antibodies have superior cancer inhibitory activity against EGFR, HER2, HER3, and VEGF through disruption of HER/MET crosstalk.
Hu S; Fu W; Xu W; Yang Y; Cruz M; Berezov SD; Jorissen D; Takeda H; Zhu W
Cancer Res; 2015 Jan; 75(1):159-70. PubMed ID: 25371409
[TBL] [Abstract][Full Text] [Related]
14. Immune-Driven Pathogenesis of Neurotoxicity after Exposure of Cancer Patients to Immune Checkpoint Inhibitors.
Vilariño N; Bruna J; Kalofonou F; Anastopoulou GG; Argyriou AA
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32796758
[TBL] [Abstract][Full Text] [Related]
15. Quantitative Sensory Testing at Baseline and During Cycle 1 Oxaliplatin Infusion Detects Subclinical Peripheral Neuropathy and Predicts Clinically Overt Chronic Neuropathy in Gastrointestinal Malignancies.
Reddy SM; Vergo MT; Paice JA; Kwon N; Helenowski IB; Benson AB; Mulcahy MF; Nimeiri HS; Harden RN
Clin Colorectal Cancer; 2016 Mar; 15(1):37-46. PubMed ID: 26337211
[TBL] [Abstract][Full Text] [Related]
16. Neurotoxicity induced by antineoplastic proteasome inhibitors.
Alé A; Bruna J; Navarro X; Udina E
Neurotoxicology; 2014 Jul; 43():28-35. PubMed ID: 24525285
[TBL] [Abstract][Full Text] [Related]
17. Skin toxicity with anti-EGFR monoclonal antibody in cancer patients: a meta-analysis of 65 randomized controlled trials.
Li J; Yan H
Cancer Chemother Pharmacol; 2018 Oct; 82(4):571-583. PubMed ID: 30006755
[TBL] [Abstract][Full Text] [Related]
18. Neurotoxicity of cancer chemotherapy.
Dropcho EJ
Semin Neurol; 2004 Dec; 24(4):419-26. PubMed ID: 15637653
[TBL] [Abstract][Full Text] [Related]
19. Dermatologic Toxicity Occurring During Anti-EGFR Monoclonal Inhibitor Therapy in Patients With Metastatic Colorectal Cancer: A Systematic Review.
Lacouture ME; Anadkat M; Jatoi A; Garawin T; Bohac C; Mitchell E
Clin Colorectal Cancer; 2018 Jun; 17(2):85-96. PubMed ID: 29576427
[TBL] [Abstract][Full Text] [Related]
20. A New Strategy Toward B Cell-Based Cancer Vaccines by Active Immunization With Mimotopes of Immune Checkpoint Inhibitors.
Tobias J; Battin C; De Sousa Linhares A; Lebens M; Baier K; Ambroz K; Drinić M; Högler S; Inic-Kanada A; Garner-Spitzer E; Preusser M; Kenner L; Kundi M; Zielinski CC; Steinberger P; Wiedermann U
Front Immunol; 2020; 11():895. PubMed ID: 32528470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]